Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Lancet HIV. 2016 Dec 16;4(3):e122–e133. doi: 10.1016/S2352-3018(16)30220-X

Table 2.

Viral Suppression by Region and ART Status

WEST UGANDA EAST UGANDA KENYA
VL Metric Region Total
(n=1,827)
On ART
(n=675)
Region Total
(n=1,147)
On ART
(n=458)
Region Total
(n=5,854)
On ART
(n=3,069)
< 500 (copies/mL) 881
(48.2%)
568
(84.2%)
516
(45.0%)
345
(75.3%)
3,093
(52.8%)
2,514
(81.9%)
500–1,000 38
(2.1%)
6
(0.9%)
28
(2.4%)
10
(2.2%)
113
(1.9%)
43
(1.4%)
1,000–10,000 284
(15.5%)
37
(5.5%)
133
(11.6%)
36
(7.9%)
722
(12.3%)
168
(5.5%)
10,001–100,000 426
(23.3%)
42
(6.2%)
290
(25.3%)
49
(10.7%)
1,198
(20.5%)
215
(7.0%)
> 100,000 198
(10.8%)
22
(3.3%)
180
(15.7%)
18
(3.9%)
728
(12.4%)
129
(4.2%)
Median VL, IQR 874
(<500—24,983)
<500
(<500—<500)
2,124
(<500—45,404)
<500
(<500—<500)
<500
(<40—24,268)
<500
(<40—<500)
Mean log10(VL)
95% CI
3.47
(3.41–3.52)
2.79
(2.73–2.86)
3.66
(3.59–3.73)
3.00
(2.92–3.08)
3.20
(3.17–3.24)
2.50
(2.46–2.54)

NOTE. VL, viral load; ART, antiretroviral therapy; IQR, interquartile range; CI, confidence interval